Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct‐acting antiviral therapy-Reference-Cited by-同舟云学术

Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct‐acting antiviral therapy

Published:2019-02-18 Issue:9 Volume:34 Page:1641-1647
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Wong Grace Lai‐Hung¹²^ORCID,Chan Henry Lik‐Yuen¹²,Loo Ching‐Kong³,Hui Yee‐Tak⁴,Fung James Yue‐Yan⁵,Cheung David⁶,Chung Cedric⁶,Chim Angel Mei‐Ling¹²,Wong Vincent Wai‐Sun¹²^ORCID,

Affiliation:

1. Institute of Digestive Disease Hong Kong

2. Department of Medicine and TherapeuticsThe Chinese University of Hong Kong Hong Kong

3. Department of MedicineKwong Wah Hospital Hong Kong

4. Department of MedicineQueen Elizabeth Hospital Hong Kong

5. Department of MedicineQueen Mary Hospital Hong Kong

6. Caritas Lok Heep Club Hong Kong

Funder

Hong Kong Association for the Study of Liver Diseases

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14622

Reference32 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

3. Chronic hepatitis C in the state prison system: insights into the problems and possible solutions

4. Drug abuse situation in Hong Kong in 2015. Website:https://www.statistics.gov.hk/pub/B71608FC2016XXXXB0100.pdf. Accessed on 1 Nov 2018.

5. New Life New Liver. Website:http://www.newliver.hk/chi/p6.htm. Accessed on 28 Dec 2018.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot model of hepatitis C virus micro-elimination in high-risk populations in Hong Kong: Barriers and facilitators;International Journal of Drug Policy;2024-10

2. THE DEVELOPMENT AND STUDY OF THE TOXICITY OF SUPPOSITORIES WITH A MODIFIED SUBSTANCE OF INTERFERON ALFA-2B;International Journal of Applied Pharmaceutics;2023-03-07

3. Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study;Hepatology International;2022-09-08

4. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma;Alimentary Pharmacology & Therapeutics;2022-07-21

5. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis;JHEP Reports;2022-03